-
Biogen Settlement Summary
08 Oct 2022 03:29 GMT
… announced a settlement resolving a lawsuit filed by former employee … .[1]
The Plaintiff’s lawsuit[2] alleged that the Company … settlement or $250 million. The lawsuit was dismissed with prejudice.
… States ex rel. Bawduniak v. Biogen Idec, Inc., No. 12-cv-10601 …
-
Biogen Inc. Agrees to Pay $900 Million to Settle Allegations Related to Improper Physician Payments
27 Sep 2022 19:40 GMT
… settlement announced today resolves a lawsuit filed and litigated by former … a relator) to file a lawsuit on behalf of the United … may proceed with the lawsuit.
In his lawsuit filed in the District … States ex rel. Bawduniak v. Biogen Idec, Inc., No. 12-cv-10601 …
-
Homology Medicines Announces Promotion of Tim Kelly to Chief Operating Officer
12 Apr 2021 12:30 GMT
… Shire plc, Sarepta Therapeutics, Inc., Biogen Idec and UCB S.A. He … healthcare reform initiatives; product liability lawsuits; failure to attract, retain and …
-
Global Ion Channel Modulators Strategic Business Report 2019: Market Analysis, Trends, and Forecasts 2015-2022
20 Feb 2019 09:26 GMT
… Develop ENaC Inhibitors
Biogen Idec Changes Name to Biogen
Biogen Idec Acquires Convergence Pharmaceuticals … , Launches Namenda XR
Forest Files Lawsuit against Namenda Generic Manufacturers
Cytocentrics …
-
Global Ion Channel Modulators Industry
28 Jan 2019 22:15 GMT
… in Cystic Fibrosis
Biogen Idec Changes Name to Biogen
Biogen Idec Acquires Convergence Pharmaceuticals … , Launches Namenda XR
Forest Files Lawsuit against Namenda Generic Manufacturers
Cytocentrics …
-
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Perrigo Company plc
21 Dec 2018 20:33 GMT
… property and related assets to Biogen Idec. Following this news, shares of … nation in securities and shareholder lawsuits. Attorney advertising. Prior results do …
-
Ion Channel Modulators Market 2015-2022: Global Strategic Business Report 2018 - Industry & Product Overview, Recent Industry Activity & Focus on Key Players
14 Feb 2018 10:08 GMT
…
in Cystic Fibrosis
Biogen Idec Changes Name to Biogen
Biogen Idec Acquires Convergence Pharmaceuticals … , Launches Namenda XR
Forest Files Lawsuit against Namenda Generic Manufacturers
Cytocentrics …
-
Ion Channel Modulators Market 2015-2022: Global Strategic Business Report 2018 - Industry & Product Overview, Recent Industry Activity & Focus on Key Players
14 Feb 2018 10:06 GMT
…
in Cystic Fibrosis
Biogen Idec Changes Name to Biogen
Biogen Idec Acquires Convergence Pharmaceuticals … , Launches Namenda XR
Forest Files Lawsuit against Namenda Generic Manufacturers
Cytocentrics …
About
© 1995-2025